Immunoinformatics Market
1 Study Coverage
1.1 Immunoinformatics Revenue in Immunoinformatics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Immunoinformatics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Immunoinformatics Market Size for the Year 2017-2028
1.2.2 Global Immunoinformatics Market Size for the Year 2017-2028
1.3 Immunoinformatics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Immunoinformatics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Immunoinformatics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Immunoinformatics Market Dynamics
1.4.1 Immunoinformatics Industry Trends
1.4.2 Immunoinformatics Market Drivers
1.4.3 Immunoinformatics Market Challenges
1.4.4 Immunoinformatics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Immunoinformatics by Type
2.1 Immunoinformatics Market Segment by Type
2.1.1 Cancer Diagnosis & Therapy
2.1.2 Reverse Vaccinology
2.1.3 Immune System Modeling
2.2 Global Immunoinformatics Market Size by Type (2017, 2022 & 2028)
2.3 Global Immunoinformatics Market Size by Type (2017-2028)
2.4 United States Immunoinformatics Market Size by Type (2017, 2022 & 2028)
2.5 United States Immunoinformatics Market Size by Type (2017-2028)
3 Immunoinformatics by Application
3.1 Immunoinformatics Market Segment by Application
3.1.1 Allergy Prediction Databases
3.1.2 Analysis Resource Database
3.1.3 International Immunogenetics System
3.1.4 The Ontology of Immune Epitopes
3.1.5 Immune Epitope Database
3.2 Global Immunoinformatics Market Size by Application (2017, 2022 & 2028)
3.3 Global Immunoinformatics Market Size by Application (2017-2028)
3.4 United States Immunoinformatics Market Size by Application (2017, 2022 & 2028)
3.5 United States Immunoinformatics Market Size by Application (2017-2028)
4 Global Immunoinformatics Competitor Landscape by Company
4.1 Global Immunoinformatics Market Size by Company
4.1.1 Top Global Immunoinformatics Companies Ranked by Revenue (2021)
4.1.2 Global Immunoinformatics Revenue by Player (2017-2022)
4.2 Global Immunoinformatics Concentration Ratio (CR)
4.2.1 Immunoinformatics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Immunoinformatics in 2021
4.2.3 Global Immunoinformatics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Immunoinformatics Headquarters, Revenue in Immunoinformatics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Immunoinformatics Headquarters and Area Served
4.3.2 Global Immunoinformatics Companies Revenue in Immunoinformatics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Immunoinformatics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Immunoinformatics Market Size by Company
4.5.1 Top Immunoinformatics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Immunoinformatics Revenue by Players (2020, 2021 & 2022)
5 Global Immunoinformatics Market Size by Region
5.1 Global Immunoinformatics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Immunoinformatics Market Size by Region (2017-2028)
5.2.1 Global Immunoinformatics Market Size by Region: 2017-2022
5.2.2 Global Immunoinformatics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Immunoinformatics Market Size YoY Growth 2017-2028
6.1.2 North America Immunoinformatics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Immunoinformatics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Immunoinformatics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Immunoinformatics Market Size YoY Growth 2017-2028
6.3.2 Europe Immunoinformatics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Immunoinformatics Market Size YoY Growth 2017-2028
6.4.2 Latin America Immunoinformatics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Immunoinformatics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Immunoinformatics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 EpiVax
7.1.1 EpiVax Company Details
7.1.2 EpiVax Business Overview
7.1.3 EpiVax Immunoinformatics Introduction
7.1.4 EpiVax Revenue in Immunoinformatics Business (2017-2022)
7.1.5 EpiVax Recent Development
7.2 Novozymes Biopharma
7.2.1 Novozymes Biopharma Company Details
7.2.2 Novozymes Biopharma Business Overview
7.2.3 Novozymes Biopharma Immunoinformatics Introduction
7.2.4 Novozymes Biopharma Revenue in Immunoinformatics Business (2017-2022)
7.2.5 Novozymes Biopharma Recent Development
7.3 ioGenetics
7.3.1 ioGenetics Company Details
7.3.2 ioGenetics Business Overview
7.3.3 ioGenetics Immunoinformatics Introduction
7.3.4 ioGenetics Revenue in Immunoinformatics Business (2017-2022)
7.3.5 ioGenetics Recent Development
7.4 International Society of Vaccines
7.4.1 International Society of Vaccines Company Details
7.4.2 International Society of Vaccines Business Overview
7.4.3 International Society of Vaccines Immunoinformatics Introduction
7.4.4 International Society of Vaccines Revenue in Immunoinformatics Business (2017-2022)
7.4.5 International Society of Vaccines Recent Development
7.5 IMGT
7.5.1 IMGT Company Details
7.5.2 IMGT Business Overview
7.5.3 IMGT Immunoinformatics Introduction
7.5.4 IMGT Revenue in Immunoinformatics Business (2017-2022)
7.5.5 IMGT Recent Development
7.6 Dassault Systemes
7.6.1 Dassault Systemes Company Details
7.6.2 Dassault Systemes Business Overview
7.6.3 Dassault Systemes Immunoinformatics Introduction
7.6.4 Dassault Systemes Revenue in Immunoinformatics Business (2017-2022)
7.6.5 Dassault Systemes Recent Development
7.7 Certara
7.7.1 Certara Company Details
7.7.2 Certara Business Overview
7.7.3 Certara Immunoinformatics Introduction
7.7.4 Certara Revenue in Immunoinformatics Business (2017-2022)
7.7.5 Certara Recent Development
7.8 Chemical Computing Group
7.8.1 Chemical Computing Group Company Details
7.8.2 Chemical Computing Group Business Overview
7.8.3 Chemical Computing Group Immunoinformatics Introduction
7.8.4 Chemical Computing Group Revenue in Immunoinformatics Business (2017-2022)
7.8.5 Chemical Computing Group Recent Development
7.9 Compugen
7.9.1 Compugen Company Details
7.9.2 Compugen Business Overview
7.9.3 Compugen Immunoinformatics Introduction
7.9.4 Compugen Revenue in Immunoinformatics Business (2017-2022)
7.9.5 Compugen Recent Development
7.10 Genedata AG
7.10.1 Genedata AG Company Details
7.10.2 Genedata AG Business Overview
7.10.3 Genedata AG Immunoinformatics Introduction
7.10.4 Genedata AG Revenue in Immunoinformatics Business (2017-2022)
7.10.5 Genedata AG Recent Development
7.11 Insilico Biotechnology AG
7.11.1 Insilico Biotechnology AG Company Details
7.11.2 Insilico Biotechnology AG Business Overview
7.11.3 Insilico Biotechnology AG Immunoinformatics Introduction
7.11.4 Insilico Biotechnology AG Revenue in Immunoinformatics Business (2017-2022)
7.11.5 Insilico Biotechnology AG Recent Development
7.12 Leadscope Inc
7.12.1 Leadscope Inc Company Details
7.12.2 Leadscope Inc Business Overview
7.12.3 Leadscope Inc Immunoinformatics Introduction
7.12.4 Leadscope Inc Revenue in Immunoinformatics Business (2017-2022)
7.12.5 Leadscope Inc Recent Development
7.13 Nimbus Discovery
7.13.1 Nimbus Discovery Company Details
7.13.2 Nimbus Discovery Business Overview
7.13.3 Nimbus Discovery Immunoinformatics Introduction
7.13.4 Nimbus Discovery Revenue in Immunoinformatics Business (2017-2022)
7.13.5 Nimbus Discovery Recent Development
7.14 Strand Life Sciences
7.14.1 Strand Life Sciences Company Details
7.14.2 Strand Life Sciences Business Overview
7.14.3 Strand Life Sciences Immunoinformatics Introduction
7.14.4 Strand Life Sciences Revenue in Immunoinformatics Business (2017-2022)
7.14.5 Strand Life Sciences Recent Development
7.15 Schrodinger
7.15.1 Schrodinger Company Details
7.15.2 Schrodinger Business Overview
7.15.3 Schrodinger Immunoinformatics Introduction
7.15.4 Schrodinger Revenue in Immunoinformatics Business (2017-2022)
7.15.5 Schrodinger Recent Development
7.16 Simulation Plus
7.16.1 Simulation Plus Company Details
7.16.2 Simulation Plus Business Overview
7.16.3 Simulation Plus Immunoinformatics Introduction
7.16.4 Simulation Plus Revenue in Immunoinformatics Business (2017-2022)
7.16.5 Simulation Plus Recent Development
7.17 Rosa & Co
7.17.1 Rosa & Co Company Details
7.17.2 Rosa & Co Business Overview
7.17.3 Rosa & Co Immunoinformatics Introduction
7.17.4 Rosa & Co Revenue in Immunoinformatics Business (2017-2022)
7.17.5 Rosa & Co Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Immunoinformatics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Immunoinformatics Market Trends
Table 3. Immunoinformatics Market Drivers
Table 4. Immunoinformatics Market Challenges
Table 5. Immunoinformatics Market Restraints
Table 6. Global Immunoinformatics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Immunoinformatics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Immunoinformatics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Immunoinformatics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Immunoinformatics Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Immunoinformatics Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Immunoinformatics Revenue Share by Player, 2017-2022
Table 13. Global Immunoinformatics Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Immunoinformatics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunoinformatics as of 2021)
Table 15. Top Players of Immunoinformatics in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Immunoinformatics Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Immunoinformatics Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Immunoinformatics Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Immunoinformatics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Immunoinformatics Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Immunoinformatics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Immunoinformatics Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Immunoinformatics Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Immunoinformatics Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Immunoinformatics Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Immunoinformatics Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Immunoinformatics Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Immunoinformatics Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. EpiVax Company Details
Table 31. EpiVax Business Overview
Table 32. EpiVax Immunoinformatics Product
Table 33. EpiVax Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 34. EpiVax Recent Development
Table 35. Novozymes Biopharma Company Details
Table 36. Novozymes Biopharma Business Overview
Table 37. Novozymes Biopharma Immunoinformatics Product
Table 38. Novozymes Biopharma Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 39. Novozymes Biopharma Recent Development
Table 40. ioGenetics Company Details
Table 41. ioGenetics Business Overview
Table 42. ioGenetics Immunoinformatics Product
Table 43. ioGenetics Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 44. ioGenetics Recent Development
Table 45. International Society of Vaccines Company Details
Table 46. International Society of Vaccines Business Overview
Table 47. International Society of Vaccines Immunoinformatics Product
Table 48. International Society of Vaccines Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 49. International Society of Vaccines Recent Development
Table 50. IMGT Company Details
Table 51. IMGT Business Overview
Table 52. IMGT Immunoinformatics Product
Table 53. IMGT Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 54. IMGT Recent Development
Table 55. Dassault Systemes Company Details
Table 56. Dassault Systemes Business Overview
Table 57. Dassault Systemes Immunoinformatics Product
Table 58. Dassault Systemes Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 59. Dassault Systemes Recent Development
Table 60. Certara Company Details
Table 61. Certara Business Overview
Table 62. Certara Immunoinformatics Product
Table 63. Certara Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 64. Certara Recent Development
Table 65. Chemical Computing Group Company Details
Table 66. Chemical Computing Group Business Overview
Table 67. Chemical Computing Group Immunoinformatics Product
Table 68. Chemical Computing Group Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 69. Chemical Computing Group Recent Development
Table 70. Compugen Company Details
Table 71. Compugen Business Overview
Table 72. Compugen Immunoinformatics Product
Table 73. Compugen Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 74. Compugen Recent Development
Table 75. Genedata AG Company Details
Table 76. Genedata AG Business Overview
Table 77. Genedata AG Immunoinformatics Product
Table 78. Genedata AG Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 79. Genedata AG Recent Development
Table 80. Insilico Biotechnology AG Company Details
Table 81. Insilico Biotechnology AG Business Overview
Table 82. Insilico Biotechnology AG Immunoinformatics Product
Table 83. Insilico Biotechnology AG Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 84. Insilico Biotechnology AG Recent Development
Table 85. Leadscope Inc Company Details
Table 86. Leadscope Inc Business Overview
Table 87. Leadscope Inc Immunoinformatics Product
Table 88. Leadscope Inc Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 89. Leadscope Inc Recent Development
Table 90. Nimbus Discovery Company Details
Table 91. Nimbus Discovery Business Overview
Table 92. Nimbus Discovery Immunoinformatics Product
Table 93. Nimbus Discovery Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 94. Nimbus Discovery Recent Development
Table 95. Strand Life Sciences Company Details
Table 96. Strand Life Sciences Business Overview
Table 97. Strand Life Sciences Immunoinformatics Product
Table 98. Strand Life Sciences Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 99. Strand Life Sciences Recent Development
Table 100. Schrodinger Company Details
Table 101. Schrodinger Business Overview
Table 102. Schrodinger Immunoinformatics Product
Table 103. Schrodinger Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 104. Schrodinger Recent Development
Table 105. Simulation Plus Company Details
Table 106. Simulation Plus Business Overview
Table 107. Simulation Plus Immunoinformatics Product
Table 108. Simulation Plus Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 109. Simulation Plus Recent Development
Table 110. Rosa & Co Company Details
Table 111. Rosa & Co Business Overview
Table 112. Rosa & Co Immunoinformatics Product
Table 113. Rosa & Co Revenue in Immunoinformatics Business (2017-2022) & (US$ Million)
Table 114. Rosa & Co Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Immunoinformatics Product Picture
Figure 2. Global Immunoinformatics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Immunoinformatics Market Size 2017-2028 (US$ Million)
Figure 4. United States Immunoinformatics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Immunoinformatics Market Size 2017-2028 (US$ Million)
Figure 6. United States Immunoinformatics Market Share in Global 2017-2028
Figure 7. Immunoinformatics Report Years Considered
Figure 8. Product Picture of Cancer Diagnosis & Therapy
Figure 9. Product Picture of Reverse Vaccinology
Figure 10. Product Picture of Immune System Modeling
Figure 11. Global Immunoinformatics Market Share by Type in 2022 & 2028
Figure 12. Global Immunoinformatics Market Size by Type (2017-2028) & (US$ Million)
Figure 13. Global Immunoinformatics Market Share by Type (2017-2028)
Figure 14. United States Immunoinformatics Market Share by Type in 2022 & 2028
Figure 15. United States Immunoinformatics Market Size by Type (2017-2028) & (US$ Million)
Figure 16. United States Immunoinformatics Market Share by Type (2017-2028)
Figure 17. Product Picture of Allergy Prediction Databases
Figure 18. Product Picture of Analysis Resource Database
Figure 19. Product Picture of International Immunogenetics System
Figure 20. Product Picture of The Ontology of Immune Epitopes
Figure 21. Product Picture of Immune Epitope Database
Figure 22. Global Immunoinformatics Market Share by Application in 2022 & 2028
Figure 23. Global Immunoinformatics Market Size by Application (2017-2028) & (US$ Million)
Figure 24. Global Immunoinformatics Market Share by Application (2017-2028)
Figure 25. United States Immunoinformatics Market Share by Application in 2022 & 2028
Figure 26. United States Immunoinformatics Market Size by Application (2017-2028) & (US$ Million)
Figure 27. United States Immunoinformatics Market Share by Application (2017-2028)
Figure 28. North America Immunoinformatics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. U.S. Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Canada Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Europe Immunoinformatics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 32. Germany Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. France Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. U.K. Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Italy Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Russia Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Immunoinformatics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 38. China Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Japan Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. South Korea Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. India Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Australia Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Taiwan Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Indonesia Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Thailand Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Malaysia Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Philippines Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Latin America Immunoinformatics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 49. Mexico Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Brazil Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Argentina Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Immunoinformatics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 53. Turkey Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. U.A.E Immunoinformatics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. EpiVax Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 57. Novozymes Biopharma Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 58. ioGenetics Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 59. International Society of Vaccines Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 60. IMGT Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 61. Dassault Systemes Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 62. Certara Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 63. Chemical Computing Group Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 64. Compugen Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 65. Genedata AG Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 66. Insilico Biotechnology AG Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 67. Leadscope Inc Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 68. Nimbus Discovery Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 69. Strand Life Sciences Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 70. Schrodinger Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 71. Simulation Plus Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 72. Rosa & Co Revenue Growth Rate in Immunoinformatics Business (2017-2022)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed